Literature DB >> 21270144

NF-kappaB activation stimulates transcription and replication of retrovirus XMRV in human B-lineage and prostate carcinoma cells.

Shuhei Sakakibara1, Kaori Sakakibara, Giovanna Tosato.   

Abstract

Xenotropic murine leukemia virus-related virus (XMRV) is a gammaretrovirus linked to prostate carcinoma and chronic fatigue syndrome. Here we report that NF-κB activation can markedly increase XMRV production. The inflammatory cytokine tumor necrosis factor alpha (TNF-α), which activates NF-κB, significantly augmented viral Gag protein production in XMRV-infected cells. Reporter assays showed that TNF-α and Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1), an intrinsic NF-κB activator, increased long terminal repeat (LTR)-dependent XMRV transcription. We identified two NF-κB binding sites (designated κB-1 and κB-2) in the LTR U3 region of XMRV and demonstrated that both sites bind to the NF-κB component p65/RelA. Mutation of the κB-1 site, but not the κB-2 site, impaired responsiveness to TNF-α and LMP1 in reporter assays. A mutant XMRV with a mutation at the κB-1 site replicated significantly less efficiently than the wild-type XMRV in the prostate carcinoma LNCaP, DU145, and PC-3 cell lines, HEK293 cells, the EBV-immortalized cell line IB4, and the Burkitt's lymphoma cell line BJAB. These results demonstrate that TNF-α and EBV LMP1 enhance XMRV replication in prostate carcinoma and B-lineage cells through the κB-1 site in the XMRV LTR, suggesting that inflammation, EBV infection, and other conditions leading to NF-κB activation may promote XMRV spread in humans.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21270144      PMCID: PMC3067858          DOI: 10.1128/JVI.02333-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  The amino-terminus and membrane-spanning domains of LMP-1 inhibit cell proliferation.

Authors:  A Kaykas; B Sugden
Journal:  Oncogene       Date:  2000-03-09       Impact factor: 9.867

2.  TNF-alpha and chronic fatigue syndrome.

Authors:  R B Moss; A Mercandetti; A Vojdani
Journal:  J Clin Immunol       Date:  1999-09       Impact factor: 8.317

3.  Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection.

Authors:  S E Straus; G Tosato; G Armstrong; T Lawley; O T Preble; W Henle; R Davey; G Pearson; J Epstein; I Brus
Journal:  Ann Intern Med       Date:  1985-01       Impact factor: 25.391

4.  The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group.

Authors:  K Fukuda; S E Straus; I Hickie; M C Sharpe; J G Dobbins; A Komaroff
Journal:  Ann Intern Med       Date:  1994-12-15       Impact factor: 25.391

5.  Molecular cloning, complete sequence, and biological characterization of a xenotropic murine leukemia virus constitutively released from the human B-lymphoblastoid cell line DG-75.

Authors:  Kevin P Raisch; Massimo Pizzato; Hai Yuan Sun; Yasuhiro Takeuchi; L William Cashdollar; Sidney E Grossberg
Journal:  Virology       Date:  2003-03-30       Impact factor: 3.616

6.  Glucocorticoid responsiveness of the transcriptional enhancer of Moloney murine sarcoma virus.

Authors:  R Miksicek; A Heber; W Schmid; U Danesch; G Posseckert; M Beato; G Schütz
Journal:  Cell       Date:  1986-07-18       Impact factor: 41.582

7.  Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells.

Authors:  Junghan Suh; Faribourz Payvandi; Leonard C Edelstein; Peter S Amenta; Wei-Xing Zong; Céline Gélinas; Arnold B Rabson
Journal:  Prostate       Date:  2002-08-01       Impact factor: 4.104

8.  A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB.

Authors:  P A Baeuerle; D Baltimore
Journal:  Genes Dev       Date:  1989-11       Impact factor: 11.361

9.  LNCaP model of human prostatic carcinoma.

Authors:  J S Horoszewicz; S S Leong; E Kawinski; J P Karr; H Rosenthal; T M Chu; E A Mirand; G P Murphy
Journal:  Cancer Res       Date:  1983-04       Impact factor: 12.701

10.  Failure to detect xenotropic murine leukemia virus-related virus in blood of individuals at high risk of blood-borne viral infections.

Authors:  Eleanor Barnes; Peter Flanagan; Anthony Brown; Nicola Robinson; Helen Brown; Myra McClure; Annette Oxenius; Jane Collier; Jonathan Weber; Huldrych F Günthard; Bernard Hirschel; Sarah Fidler; Rodney Phillips; John Frater
Journal:  J Infect Dis       Date:  2010-10-11       Impact factor: 5.226

View more
  7 in total

Review 1.  Is XMRV a causal virus for prostate cancer?

Authors:  Zhen-Zhen Zhang; Bao-Feng Guo; Zhuang Feng; Ling Zhang; Xue-Jian Zhao
Journal:  Asian J Androl       Date:  2011-07-18       Impact factor: 3.285

2.  A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein.

Authors:  S Sakakibara; G Espigol-Frigole; P Gasperini; T S Uldrick; R Yarchoan; G Tosato
Journal:  Oncogene       Date:  2012-04-23       Impact factor: 9.867

3.  Prevention of contamination by xenotropic murine leukemia virus-related virus: susceptibility to alcohol-based disinfectants and environmental stability.

Authors:  David Palesch; Mohammad Khalid; Christina M Stürzel; Jan Münch
Journal:  Appl Environ Microbiol       Date:  2014-02-14       Impact factor: 4.792

4.  The shrimp NF-κB pathway is activated by white spot syndrome virus (WSSV) 449 to facilitate the expression of WSSV069 (ie1), WSSV303 and WSSV371.

Authors:  Pei-Hui Wang; Zhi-Hua Gu; Ding-Hui Wan; Ming-Yan Zhang; Shao-Ping Weng; Xiao-Qiang Yu; Jian-Guo He
Journal:  PLoS One       Date:  2011-09-12       Impact factor: 3.240

5.  XMRV Discovery and Prostate Cancer-Related Research.

Authors:  David E Kang; Michael C Lee; Jaydip Das Gupta; Eric A Klein; Robert H Silverman
Journal:  Adv Virol       Date:  2011-06-21

6.  Utilization of replication-competent XMRV reporter-viruses reveals severe viral restriction in primary human cells.

Authors:  Christina Martina Stürzel; David Palesch; Mohammad Khalid; Silke Wissing; Nicole Fischer; Jan Münch
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

Review 7.  Prostate Microbiota and Prostate Cancer: A New Trend in Treatment.

Authors:  Bangwei Che; Wenjun Zhang; Shenghan Xu; Jingju Yin; Jun He; Tao Huang; Wei Li; Ying Yu; Kaifa Tang
Journal:  Front Oncol       Date:  2021-12-10       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.